Article
Not enough can be enough: feasibility of the Idylla EGFR mutation test when reuse of stained tissue slides is the only option available.
Journal of clinical pathology - 1 Dec 2022
Ercolani Cristiana, Di Benedetto Anna, Bonomo Claudia, Visca Paolo, Palange Aldo, Assisi Daniela, Forcella Daniele, Terrenato Irene, Pescarmona Edoardo, Ciliberto Gennaro, Cecere Fabiana Letizia, Cappuzzo Federico, Buglioni Simonetta
Abstract excerpt
AIMS: The minimally invasive procedures used in the diagnostic workup of patients with advanced non-small cell lung cancer (NSCLC) often provide poor yields of pathological material suitable for molecular analyses. Not infrequently, the DNA yield from small biopsies/cytological samples is insufficient for the assessment of genomic biomarkers that inform personalised therapies. The Idylla EGFR mutation test (IEMT)...
Topics
Join the communities discussing this publication.
